Optional product analytics
With your permission, we use privacy-limited analytics to understand which research journeys work. We do not run advertising trackers or session replay. You can change this choice in Preferences. Read the Privacy Policy.
CSX Corporation's published Sell conclusion compares the analysis-date price with fair value and potential value. Read the full report for assumptions, evidence, and material risks.
| Market cap | $90.8B | |
|---|---|---|
| Revenue (ttm) | 14.9B | |
| Net income (ttm) | 3.6B | |
| EPS (ttm) | $1.92 | |
| Shares out | 1.8B | |
| P/E (trailing) | 27.0x | |
| P/E (forward) | 21.9x | |
| Dividend | $0.56 (1.08%) | |
| Volume | 6,815,670 | |
| Beta | 1.20 |
Recent price action with selectable time range.
| Item | P1 | P2 | P3 | P4 | P5 | Trend |
|---|---|---|---|---|---|---|
| Period | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Trend |
| Revenue | $12.52B | $14.85B | $14.66B | $14.54B | $14.09B | +3.0% |
| Gross profit | $5.29B | $5.72B | $5.60B | $5.51B | $4.69B | -3.0% |
| Operating income | $5.59B | $5.95B | $5.50B | $5.25B | $4.52B | -5.2% |
| Net income | $3.78B | $4.11B | $3.67B | $3.47B | $2.89B | -6.5% |
| EPS (diluted) | $1.68 | $1.92 | $1.82 | $1.79 | $1.54 | -2.2% |
| EBITDA | $7.09B | $7.59B | $7.27B | $7.07B | $5.87B | -4.6% |
| R&D | — | — | — | — | — | — |
| SG&A | $64.0M | $79.0M | $29.0M | $50.0M | $33.0M | -15.3% |
Recent company headlines from major financial publishers.
Positive rail growth supports a measured recovery. This path fails if rail growth stalls, operating margin misses the Base endpoint, or investment intensity remains elevated through FY2028.
The higher outcome needs stronger operations and cash than Base. Persistent rail growth and a higher margin raise profit; lower investment spending must then turn more of that profit into free cash flow.
| Ke ↓ / g → | 0.5% | 0.5% | 1.0% | 1.5% | 2.0% |
|---|---|---|---|---|---|
| 6.6% | $27.9 | $27.9 | $29.0 | $30.3 | $31.9 |
| 7.6% | $25.4 | $25.4 | $26.2 | $27.1 | $28.2 |
| 8.6% | $23.6 | $23.6 | $24.1 | $24.8 | $25.5 |
| 9.6% | $22.1 | $22.1 | $22.5 | $23.0 | $23.5 |
| 10.6% | $20.9 | $20.9 | $21.2 | $21.6 | $22.0 |
Upcoming earnings date and setup when available.
The rating each month's published research edition carried. A rating compares the price at analysis with the Fair value; it is not a record of whether the call was right.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 |
